UPDATE : Monday, October 14, 2019
상단여백
Severance confirms efficacy, safety of Yuhan's lung cancer drug Lazertinib
Severance Hospital said it has published research results on the efficacy a...
by Lee Han-soo  |  2019-10-04 14:39
라인
Samsung execs pass buck to biotech subsidiaries for destroying evidence
Samsung executives said Samsung BioLogics and Samsung Bioepis workers were ...
by Jeong Sae-im  |  2019-10-04 11:42
라인
Foreign patients visiting Korea rise by 17.8% in 2018
The number of foreigners getting medical treatment in Korea increased last ...
by Lee Han-soo  |  2019-10-02 17:50
라인
Eisai’s hepatocellular carcinoma treatment Lenvima to get insurance benefit
The government said it would grant insurance benefit to Eisai’s Lenvima (in...
by Lee Han-soo  |  2019-10-02 16:10
라인
CDK4/6 inhibitor+fulvestrant combo nears getting benefit
The combination therapy of cyclin-dependent kinase 4/6 (CDK 4/6) inhibitor ...
by Kim Yun-mi  |  2019-10-02 16:03
라인
Daewoong's EU partner wins sales approval for BTX
Daewoong Pharmaceutical said that Evolus, its U.S. and EU partner, has rece...
by Lee Han-soo  |  2019-10-02 14:51
라인
Authorities to test drugs of ranitidine family for carcinogen risk
The Ministry of Food and Drug Safety said it might test all stomach medicin...
by Lee Hye-seon  |  2019-10-02 14:51
라인
Anorexia craze among Korean girls raises concerns
The fear of weight gain and the desire to be slim has become a real health ...
by Lee Han-soo  |  2019-10-02 11:34
라인
Regulator raids cell therapy makers too often to little avail
In the wake of the recall of cell gene therapy Invossa-K, the Ministry of F...
by Jeong Sae-im  |  2019-10-02 11:23
라인
Daewoong's reaffirms drug-marketing power with Daiichi Sankyo's NOAC treatment
Daewoong proved its sales power once again as it solidified its top positio...
by Lee Han-soo  |  2019-10-01 16:43
라인
Cost of smartphone-related illness tops ₩400 billion in 2018
Medical expenses to treat smartphone-related diseases such as dry eye syndr...
by Lee Han-soo  |  2019-10-01 15:47
라인
Will parliamentary audit uncover why Invossa was mislabeled?
The National Assembly’s Health and Welfare Committee is expected to focus o...
by Jeong Sae-im  |  2019-10-01 15:45
라인
Researchers say global anti-thrombotic drug guideline too much for Koreans
Amid the controversy over the bleeding complications of anti-thrombotic dru...
by Lee Han-soo  |  2019-10-01 14:08
라인
Drugmakers’ illegal rebates down, support for doctors up
Pharmaceutical companies’ offering of illicit rebates to physicians have de...
by Kwak Sung-sun  |  2019-10-01 13:49
라인
Crystal Genomics confirms efficacy of epigenetics-based pulmonary fibrosis treatment
Crystal Genomics said it has presented the results of the preclinical study...
by Lee Han-soo  |  2019-10-01 11:21
라인
‘Merck Korea unilaterally lays off employees’
Merck Biopharma Korea has been embroiled in a labor dispute.Merck Korea bra...
by Kim Yun-mi  |  2019-10-01 11:09
라인
Allergan to compensate breast implant recipients for damage
Allergan agreed to provide full compensation for the medical expenses of pa...
by Lee Hye-seon  |  2019-09-30 15:33
라인
Ranitidine recall taking heavy toll on pharmaceuticals
Pharmaceutical companies are expected to suffer massive losses due to the r...
by Jeong Sae-im  |  2019-09-30 15:16
라인
Sale of Novartis’ conjunctivitis drug Pataday banned for 3 months
The Ministry of Food and Drug Safety has suspended the sale of Novartis Kor...
by Lee Hye-seon  |  2019-09-30 11:25
라인
Drug regulator under fire for going too far, too late
The Ministry of Food and Drug Safety (MFDS)'s ability and credibility a...
by Lee Han-soo  |  2019-09-27 17:48
여백
여백
여백
Back to Top